Showing results (21-30 of 127) with videos related to
Sort By:
Pageof 13
Molecular Diagnosis & Therapy|March 12, 2015
Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assayF Anthony Greco, Wayne J Lennington, David R Spigel, et al.Gynecologic Oncology|March 26, 2005
Paclitaxel, carboplatin, and oral etoposide as initial treatment for advanced ovarian carcinoma: a Minnie Pearl Cancer Research Network phase II trialJohn D Hainsworth, Leonard Kalman, Michael Castine, et al.Journal of the National Cancer Institute|May 4, 2013
Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathologyF Anthony Greco, Wayne J Lennington, David R Spigel, et al.Cancer|May 26, 2004
Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma: a Minnie Pearl Cancer Research Network phase II trialJohn D Hainsworth, Donna Carrell, Ronald L Drengler, et al.Clinical Colorectal Cancer|October 18, 2011
A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profileJohn D Hainsworth, Catherine A Schnabel, Mark G Erlander, et al.Clinical Lymphoma|July 3, 2003
First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trialJohn D Hainsworth, Sharlene Litchy, M Ray Lamb, et al.Cancer Treatment Reviews|May 15, 2022
Systematic review of the CUP trials characteristics and perspectives for next-generation studiesElie Rassy, Chris Labaki, Roy Chebel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2005
Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma--a randomized phase II trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Sharlene Litchy, Don W Shaffer, et al.Clinical Genitourinary Cancer|May 30, 2006
Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Anthony A Meluch, David R Spigel, et al.Cancer|June 11, 2008
Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, David R Spigel, John Barton, et al.Pageof 13